$XHR
Xenia Hotels & Resorts, Inc. Stock $xhr

$xhr Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000161600021000058 Filed on May 06, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$87.85M	$215.4M
YoY Change	-59.21%	-26.67%
Cost Of Revenue	$77.08M	$170.9M
YoY Change	-54.88%	-12.78%
Gross Profit	$10.77M	$44.50M
YoY Change	-75.8%	-54.5%
Gross Profit Margin	12.26%	20.66%
Selling, General & Admin	$47.10M	$85.60M
YoY Change	-44.98%	-7.26%
% of Gross Profit	437.41%	192.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$32.93M	$36.45M
YoY Change	-9.65%	-7.2%
% of Gross Profit	305.8%	81.91%
Operating Expenses	$80.20M	$122.6M
YoY Change	-34.58%	-7.33%
Operating Profit	-$39.18M	-$31.54M
YoY Change	24.2%	-187.44%
Interest Expense	$18.75M	$13.02M
YoY Change	43.96%	3.47%
% of Operating Profit
Other Income/Expense, Net	$116.0K	$127.0K
YoY Change	-8.66%	33.68%
Pretax Income	-$57.81M	-$44.44M
YoY Change	30.09%	-290.17%
Income Tax	$200.0K	-$7.300M
% Of Pretax Income
Net Earnings	-$56.35M	-$36.14M
YoY Change	55.93%	-316.36%
Net Earnings / Revenue	-64.14%	-16.78%
Basic Earnings Per Share	-$0.50	-$0.32
Diluted Earnings Per Share	-$0.50	-$0.32
COMMON SHARES
Basic Shares Outstanding	113.8M shares	113.0M shares
Diluted Shares Outstanding	113.8M shares	113.0M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$354.6M	$396.8M
YoY Change	-10.64%	432.62%
Cash & Equivalents	$354.6M	$396.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$14.60M	$23.50M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$369.2M	$420.3M
YoY Change	-12.16%	205.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.562B	$2.960B
YoY Change	-13.45%	2.25%
Goodwill	$4.850M	$8.584M
YoY Change	-43.5%	-65.66%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$34.60M	$79.50M
YoY Change	-56.48%	13.9%
Total Long-Term Assets	$2.654B	$3.096B
YoY Change	-14.3%	1.74%
TOTAL ASSETS
Total Short-Term Assets	$369.2M	$420.3M
Total Long-Term Assets	$2.654B	$3.096B
Total Assets	$3.023B	$3.517B
YoY Change	-14.04%	10.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$61.60M	$79.20M
YoY Change	-22.22%	-13.63%
Accrued Expenses	$23.80M	$27.10M
YoY Change	-12.18%	-2.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$85.40M	$138.1M
YoY Change	-38.16%	-8.72%
LONG-TERM LIABILITIES
Long-Term Debt	$1.374B	$1.633B
YoY Change	-15.85%	41.99%
Other Long-Term Liabilities	$49.70M	$65.00M
YoY Change	-23.54%	40.09%
Total Long-Term Liabilities	$1.424B	$1.698B
YoY Change	-16.14%	41.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$85.40M	$138.1M
Total Long-Term Liabilities	$1.424B	$1.698B
Total Liabilities	$1.509B	$1.836B
YoY Change	-17.8%	36.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$569.4M	-$385.9M
YoY Change	47.55%	46.18%
Common Stock	$1.138M	$1.135M
YoY Change	0.26%	0.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.501B	$1.669B
YoY Change
Total Liabilities & Shareholders Equity	$3.023B	$3.517B
YoY Change	-14.04%	10.54%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$56.35M	-$36.14M
YoY Change	55.93%	-316.36%
Depreciation, Depletion And Amortization	$32.93M	$36.45M
YoY Change	-9.65%	-7.2%
Cash From Operating Activities	-$31.16M	$5.387M
YoY Change	-678.43%	-83.99%
INVESTING ACTIVITIES
Capital Expenditures	-$7.200M	-$22.20M
YoY Change	-67.57%	66.92%
Acquisitions
YoY Change
Other Investing Activities	$700.0K	$2.000M
YoY Change	-65.0%
Cash From Investing Activities	-$6.547M	-$20.18M
YoY Change	-67.55%	52.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$2.300M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.854M	$296.2M
YoY Change	-100.63%	-884.81%
NET CHANGE
Cash From Operating Activities	-$31.16M	$5.387M
Cash From Investing Activities	-$6.547M	-$20.18M
Cash From Financing Activities	-$1.854M	$296.2M
Net Change In Cash	-$39.56M	$281.4M
YoY Change	-114.06%	-1720.78%
FREE CASH FLOW
Cash From Operating Activities	-$31.16M	$5.387M
Capital Expenditures	-$7.200M	-$22.20M
Free Cash Flow	-$23.96M	$27.59M
YoY Change	-186.85%	-41.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001616000
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssets
CY2021Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilities
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-36594
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	Xenia Hotels & Resorts, Inc.
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	113804074	shares
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-0141677
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 S. Orange Avenue
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2700
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32801
CY2021Q1	dei	City Area Code CityAreaCode	407
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	246-8100
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2021Q1	dei	Trading Symbol TradingSymbol	XHR
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	us-gaap	Land Land	446805000	USD
CY2020Q4	us-gaap	Land Land	446855000	USD
CY2021Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2952672000	USD
CY2020Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2949114000	USD
CY2021Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	3399477000	USD
CY2020Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	3395969000	USD
CY2021Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	860331000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	827501000	USD
CY2021Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	2539146000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	2568468000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	354597000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	389823000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	34628000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	38963000	USD
CY2021Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	14567000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	8966000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3434000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3183000	USD
CY2021Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	6204000	USD
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	6456000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	73620000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	66927000	USD
CY2021Q1	us-gaap	Assets Assets	3022762000	USD
CY2020Q4	us-gaap	Assets Assets	3079603000	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	1374038000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	1374480000	USD
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	61635000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	62676000	USD
CY2021Q1	us-gaap	Other Liabilities OtherLiabilities	73402000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	75584000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	1509075000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1512740000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113804074	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113804074	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113755513	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113755513	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	1138000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1138000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2081091000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2080364000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12059000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14425000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-569353000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-513002000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1500817000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1554075000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	12870000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	12788000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1513687000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1566863000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3022762000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3079603000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	87852000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	215353000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	77084000	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	170858000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	33197000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	246897000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	127000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37091000	USD
CY2021Q1	xhr	Real Estate Taxes Personal Property Taxes And Insurance RealEstateTaxesPersonalPropertyTaxesAndInsurance	10540000	USD
CY2020Q1	xhr	Real Estate Taxes Personal Property Taxes And Insurance RealEstateTaxesPersonalPropertyTaxesAndInsurance	13675000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	403000	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	754000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6922000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8151000	USD
CY2021Q1	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	1116000	USD
CY2020Q1	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	0	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	16368000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	127030000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-39178000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-31544000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	116000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	18750000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	13024000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57812000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44441000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	165000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7311000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-57977000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-37130000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1626000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-992000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-56351000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-36138000	USD
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	113780388	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112984868	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	113780388	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112984868	shares
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-57977000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-37130000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	104000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-17120000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-2330000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-409000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-55543000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-53841000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1558000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1477000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53985000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-52364000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1566863000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-57977000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2685000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	318000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	104000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-2330000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1513687000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1775158000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-37130000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2264000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	31633000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2371000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	475000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	-8623000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-17120000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-409000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1680693000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-57977000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-37130000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	32929000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	36448000	USD
CY2021Q1	xhr	Noncash Ground Rent And Amortization Of Other Intangibles NoncashGroundRentAndAmortizationOfOtherIntangibles	268000	USD
CY2020Q1	xhr	Noncash Ground Rent And Amortization Of Other Intangibles NoncashGroundRentAndAmortizationOfOtherIntangibles	737000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1767000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	623000	USD
CY2021Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
CY2020Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	16368000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2295000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2040000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	5604000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-13084000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8286000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15646000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	212000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9526000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3236000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1611000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31160000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5387000	USD
CY2021Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	7242000	USD
CY2020Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	22177000	USD
CY2021Q1	xhr	Proceeds From Performance Guaranty Payments ProceedsFromPerformanceGuarantyPayments	695000	USD
CY2020Q1	xhr	Proceeds From Performance Guaranty Payments ProceedsFromPerformanceGuarantyPayments	0	USD
CY2021Q1	us-gaap	Proceeds From Deposits On Real Estate Sales ProceedsFromDepositsOnRealEstateSales	0	USD
CY2020Q1	us-gaap	Proceeds From Deposits On Real Estate Sales ProceedsFromDepositsOnRealEstateSales	2000000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6547000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20177000	USD
CY2021Q1	xhr	Repayments Of Secured Debt Principal Payments RepaymentsOfSecuredDebtPrincipalPayments	1357000	USD
CY2020Q1	xhr	Repayments Of Secured Debt Principal Payments RepaymentsOfSecuredDebtPrincipalPayments	691000	USD
CY2021Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2020Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	340000000	USD
CY2021Q1	xhr	Payments For Redemption Of Partnership Capital Units PaymentsForRedemptionOfPartnershipCapitalUnits	0	USD
CY2020Q1	xhr	Payments For Redemption Of Partnership Capital Units PaymentsForRedemptionOfPartnershipCapitalUnits	8623000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2264000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	443000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	625000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	54000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	31608000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1854000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	296189000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-39561000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	281399000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	428786000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	194946000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	389225000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	476345000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	354597000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	396816000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	34628000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	79529000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	389225000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	476345000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	24814000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	11770000	USD
CY2021Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	72000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2203000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	368000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2655000	USD
CY2021Q1	us-gaap	Nature Of Operations NatureOfOperations	Organization<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xenia Hotels & Resorts, Inc. (the "Company" or "Xenia") is a Maryland corporation that primarily invests in uniquely positioned luxury and upper upscale hotels and resorts in the Top 25 lodging markets as well as key leisure destinations in the United States ("U.S."). </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company's assets are held by, and all the operations are conducted through, XHR LP (the "Operating Partnership"). XHR GP, Inc. is the sole general partner of XHR LP and is wholly-owned by the Company. As of March 31, 2021, the Company collectively owned 97.2% of the common limited partnership units issued by the Operating Partnership ("Operating Partnership Units"). The remaining 2.8% of the Operating Partnership Units are owned by the other limited partners comprised of certain of our current executive officers and members of our Board of Directors and includes vested and unvested long-term incentive plan ("LTIP") partnership units. LTIP partnership units may or may not vest based on the passage of time and meeting certain market-based performance objectives. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xenia operates as a real estate investment trust ("REIT"). To qualify as a REIT the Company cannot operate or manage its hotels. Therefore, the Operating Partnership and its subsidiaries lease the hotel properties to XHR Holding, Inc. and its subsidiaries (collectively with its subsidiaries, "XHR Holding"), the Company's taxable REIT subsidiary ("TRS"), which engages third-party eligible independent contractors to manage the hotels. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021 and 2020, the Company owned 35 and 39 lodging properties, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19 </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, confirmed cases of novel coronavirus and related respiratory disease ("COVID-19") started appearing in the United States. By March 2020, COVID-19 was deemed a global pandemic by the World Health Organization. This led federal, state and local governments in the United States to impose measures intended to control its spread, including restrictions on freedom of movement and business operations such as travel bans, border closings, business closures, school closures, quarantines, shelter-in-place orders and social distancing requirements, and also to implement phased, multi-step policies governing re-opening regions of the country. The effects of the COVID-19 pandemic on the hotel industry have been significant and unprecedented with global demand for lodging drastically reduced and occupancy levels reaching historic lows. As a result of the COVID-19 pandemic, the majority of the Company's hotels and resorts temporarily suspended operations for certain periods of time during 2020. As of March 31, 2021, Hyatt Regency Portland at the Oregon Convention Center is the Company's only hotel that continues to have suspended operations.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leisure demand gradually improved during the second half of 2020, a trend that accelerated during the first quarter of 2021; however, consistent with trends throughout the U.S. lodging industry, business transient and group demand continues to be limited.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently expect that the recovery in lodging, particularly with respect to business transient and group business, will be gradual, likely inconsistent, and may lag behind the recovery of other industries. Factors such as public health (including a significant increase in new variant strains of COVID-19 cases), availability and effectiveness of COVID-19 vaccines and therapeutics, the level of acceptance of the vaccine by the general population and the economic and geopolitical environments may impact the timing, extent and pace of such recovery. We cannot predict with certainty when business will return to normalized levels after the effects of the pandemic subside or whether hotels that have recommenced operations will be forced to shut down operations or impose additional restrictions due to a resurgence of COVID-19 cases.</span></div>
CY2021Q1	xhr	Number Of Top Lodging Markets For Investing NumberOfTopLodgingMarketsForInvesting	25	market
CY2021Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	35	property
CY2020Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	39	property
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	ReclassificationsCertain prior year amounts in these condensed consolidated financial statements have been reclassified to conform to the presentation as of and for the three months ended March 31, 2021.
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and revenues and expenses. These estimates are prepared using management's best judgment, after considering past, current and expected future economic conditions. Actual results could differ from these estimates.</span></div>
CY2021Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risks and Uncertainties</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the COVID-19 pandemic, the majority of the Company's hotels and resorts temporarily suspended operations for certain periods of time during 2020. As of March 31, 2021, Hyatt Regency Portland at the Oregon Convention Center is the Company's only hotel that continues to have suspended operations. The Company's portfolio consists of luxury and upper upscale hotels and resorts, which generally offer restaurant and bar venues, large meeting facilities and event space, and amenities, including spas and golf courses, some of which may have limited operations or will not be operating during the recovery in order to comply with implemented safety measures, ongoing restrictions and to accommodate reduced levels of demand. The Company continues to monitor the evolving situation and guidance from federal, state and local governmental and public health authorities, and additional actions may be taken or required based on their recommendations and regulations in place. Under these circumstances, there may be developments that require further operations adjustments. </span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict with certainty when business levels will return to normalized levels after the effects of the pandemic subside or whether hotels that have recommenced operations will be forced to suspend operations or impose additional restrictions due to a resurgence of COVID-19 cases. The Company expects that recovery in the lodging industry, particularly with respect to business transient and group business, will lag behind the recovery of other industries and factors such as public health (including a significant increase in new variant strains of COVID-19 cases), availability and effectiveness of COVID-19 vaccines and therapeutics, the level of acceptance of the vaccine by the general population and the economic and geopolitical environments may impact the timing, extent and pace of such recovery. Additionally, the effects of the pandemic could materially and adversely affect the Company's ability to consummate acquisitions and dispositions of hotel properties in the near term as well as cause scale backs or delays in planned renovations and other projects. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict with certainty the full extent and duration of the effects of the COVID-19 pandemic on its business, operating margins, results of operations, cash flows, financial condition, the market price of its common stock, its ability to make distributions to its shareholders, its access to equity and credit markets or its ability to service its indebtedness. Further, we continue to monitor and evaluate the challenges associated with the evolving workforce landscape, particularly related to achieving the appropriate balance between hotel staffing levels and demand as business at our hotels increases.</span></div>
CY2021Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2021Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	4900000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	4900000	USD
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16400000	USD
CY2020Q1	xhr	Goodwill Impairment Number Of Properties GoodwillImpairmentNumberOfProperties	2	property
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	87852000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	215353000	USD
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	14977000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	15892000	USD
CY2021Q1	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.0478
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	1374038000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	1374480000	USD
CY2021Q1	xhr	Debt Instrument Covenant Compliance Number Of Noncompliance DebtInstrumentCovenantComplianceNumberOfNoncompliance	4	debt_covenant
CY2021Q1	xhr	Debt Instrument Carrying Amount And Line Of Credit DebtInstrumentCarryingAmountAndLineOfCredit	1389000000	USD
CY2020Q4	xhr	Debt Instrument Carrying Amount And Line Of Credit DebtInstrumentCarryingAmountAndLineOfCredit	1390000000	USD
CY2021Q1	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.0478
CY2020Q4	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.0478
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	2533000	USD
CY2021Q1	xhr	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year Weighted Average Interest Rate LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYearWeightedAverageInterestRate	0.0434
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	4620000	USD
CY2021Q1	xhr	Long Term Debt Maturities Repayments Of Principal In Year One Weighted Average Interest Rate LongTermDebtMaturitiesRepaymentsOfPrincipalInYearOneWeightedAverageInterestRate	0.0421
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	209258000	USD
CY2021Q1	xhr	Long Term Debt Maturities Repayments Of Principal In Year Two Weighted Average Interest Rate LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoWeightedAverageInterestRate	0.0387
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	278780000	USD
CY2021Q1	xhr	Long Term Debt Maturities Repayments Of Principal In Year Three Weighted Average Interest Rate LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeWeightedAverageInterestRate	0.0379
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	567138000	USD
CY2021Q1	xhr	Long Term Debt Maturities Repayments Of Principal In Year Four Weighted Average Interest Rate LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourWeightedAverageInterestRate	0.0621
CY2021Q1	xhr	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	163593000	USD
CY2021Q1	xhr	Long Term Debt Maturities Repayments Of Principal After Year Four Weighted Average Interest Rate LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFourWeightedAverageInterestRate	0.0459
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1225922000	USD
CY2021Q1	xhr	Longterm Debt Gross Weighted Average Interest Rate LongtermDebtGrossWeightedAverageInterestRate	0.0503
CY2021Q1	us-gaap	Line Of Credit LineOfCredit	163093000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0293
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	14977000	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	1374038000	USD
CY2021Q1	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.0478
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	104000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-17120000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-2330000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-409000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	18750000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	13024000	USD
CY2021Q1	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	-9200000	USD
CY2021Q1	us-gaap	Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1 DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1	P12M
CY2021Q1	us-gaap	Goodwill Gross GoodwillGross	34352000	USD
CY2020Q4	us-gaap	Goodwill Gross GoodwillGross	34352000	USD
CY2021Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	29502000	USD
CY2020Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	29502000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	4850000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	4850000	USD
CY2020Q1	xhr	Goodwill Impairment Analysis Number Of Hotels GoodwillImpairmentAnalysisNumberOfHotels	3	property
CY2021Q1	xhr	Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate	0.0245
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2020Q1	xhr	Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate	0.1010
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7300000	USD
CY2021Q1	xhr	Common Stock Maximum Authorized Pursuant To At The Market Agreements Value CommonStockMaximumAuthorizedPursuantToAtTheMarketAgreementsValue	200000000	USD
CY2020Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2021Q1	xhr	Common Stock Remaining Available Pursuant To At The Market Agreements Value CommonStockRemainingAvailablePursuantToAtTheMarketAgreementsValue	62600000	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2020Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	165516	shares
CY2020Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	13.68
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2300000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2020Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2020-03-31
CY2020Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2020-04-15
CY2020Q1	us-gaap	Partners Capital Account Units Redeemed PartnersCapitalAccountUnitsRedeemed	457017	shares
CY2020Q1	xhr	Payments For Redemption Of Partnership Capital Units PaymentsForRedemptionOfPartnershipCapitalUnits	8600000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-56351000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-36138000	USD
CY2021Q1	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	0	USD
CY2020Q1	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	150000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-56351000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36288000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	113780388	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112984868	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	113780388	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112984868	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	546124	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	327475	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1882197	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	898676	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	153631	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	4291	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2622951	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	11.56
CY2021Q1	xhr	Operating Lease Including Available Extension Options Weighted Average Remaining Lease Term OperatingLeaseIncludingAvailableExtensionOptionsWeightedAverageRemainingLeaseTerm	P59Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0031
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	20400000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	400000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P24Y
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0579
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22364000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	23752000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	392000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	764000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	1156000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1695000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2273000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2287000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2302000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2317000	USD
CY2021Q1	xhr	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	34926000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	45800000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	22048000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	23752000	USD

Files In Submission

Name	View Source	Status
0001616000-21-000058-index-headers.html	Edgar Link	pending
0001616000-21-000058-index.html	Edgar Link	pending
0001616000-21-000058.txt	Edgar Link	pending
0001616000-21-000058-xbrl.zip	Edgar Link	pending
exhibit311_2021q1x10q.htm	Edgar Link	pending
exhibit312_2021q1x10q.htm	Edgar Link	pending
exhibit321_2021q1x10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xhr-20210331.htm	Edgar Link	pending
xhr-20210331.xsd	Edgar Link	pending
xhr-20210331_cal.xml	Edgar Link	unprocessable
xhr-20210331_def.xml	Edgar Link	unprocessable
xhr-20210331_htm.xml	Edgar Link	completed
xhr-20210331_lab.xml	Edgar Link	unprocessable
xhr-20210331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XHR
Xenia Hotels & Resorts, Inc. Stock $xhr

2021 Q1 Form 10-Q Financial Statement

#000161600021000058 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XHR Xenia Hotels & Resorts, Inc. Stock $xhr

2021 Q1 Form 10-Q Financial Statement

#000161600021000058 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XHR
Xenia Hotels & Resorts, Inc. Stock $xhr